April Weisbruch is speaking on a panel at the American Conference Institute’s (ACI) Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA) Webinar during the second week of their Proficiency Series. Her panel will address the pros and cons of participating in the BPCIA patent framework and explore the controversies in the aBLA information exchange.

ACI’s Proficiency Series provides immersive weekly classes for three weeks with the objective of attendees becoming proficient in Hatch-Waxman and BPCIA essentials. To learn more about their virtual program, visit their website.